lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

4 rows where filing_uuid = "751ebd2d-e086-4c61-8bff-ca32dd4edd63" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: received_date (date)

issue_code 4

filing_year 1

filing_period 1

id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1347683 THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 Q4 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter CPT Issues related to the Patent Reform Act of 2011, S.23. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-19T22:13:20.820000-05:00
1347684 THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 Q4 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter HCR Issues related to the implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012, Public Law No: 112-144. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-19T22:13:20.820000-05:00
1347685 THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 Q4 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter MMM Issues related to the Patient Protection and Affordable Care Act, P.L. 111-148: Medicare issues related to the Independent Payment Advisory Board (IPAB), Medicare funding issues, P.L. 112-25, the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012, H.R. 8. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-19T22:13:20.820000-05:00
1347686 THE INGRAM GROUP LLC 751ebd2d-e086-4c61-8bff-ca32dd4edd63 Q4 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 fourth_quarter PHA Issues related to pharmaceutical importation, generic drug pricing and the FAIR Generics Act, S.1882. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-01-19T22:13:20.820000-05:00

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);